Position in MRNA
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$172,888,310
+$64,574,227 QoQ
Shares Held
2,468,775
+15.8% QoQ
Ownership
0.618%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#22
of 777 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 76%
Shared 20%
None 4%
Common Shares in MRNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DIMENSIONAL FUND ADVISORS LP holds $6,103,850,879 across 229 Biotechnology names. MRNA ranks #9 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,168,956 | $580,655,511 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
1,713,592 | $412,924,262 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
559,687 | $348,987,230 | |
| 4 | INCY |
Incyte Corp
|
2,280,803 | $258,551,825 | |
| 5 | EXEL |
Exelixis, Inc.
|
4,426,620 | $240,852,392 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
4,075,714 | $233,212,353 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
5,230,417 | $185,104,455 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
476,038 | $176,929,041 |
All Filings in MRNA
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $172,888,310 | 2,468,775 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $108,314,083 | 2,132,167 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $52,756,163 | 1,788,951 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $20,706,333 | 801,639 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $30,610,192 | 1,109,467 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $43,404,699 | 1,531,030 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $69,408,951 | 1,669,287 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $122,033,850 | 1,826,034 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $169,491,873 | 1,427,300 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $148,942,533 | 1,397,734 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $129,997,457 | 1,307,164 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $189,848,360 | 1,838,013 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $269,428,192 | 2,217,516 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $393,157,732 | 2,559,954 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $421,921,809 | 2,348,969 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $248,981,403 | 2,105,551 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $179,737,009 | 1,258,222 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $170,102,960 | 987,478 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $238,670,847 | 939,723 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $240,322,363 | 624,441 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $67,412,942 | 286,888 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $37,466,235 | 286,111 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $35,158,751 | 336,544 | Shares | Defined | 2021-03-08 | |
| 2020-09-30 | $18,573,077 | 262,517 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $15,753,024 | 245,336 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $1,427,327 | 47,657 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||